Advertisement
Review article| Volume 7, ISSUE 4, P466-480, August 1993

Adenosine and myocardial protection

  • John A. Gatell
    Affiliations
    From the Department of Anesthesiology, Syosset Community Hospital, Syosset, NY, USA

    Division of Cardiothoracic Surgery, Long Island Jewish Medical Center, USA

    The Albert Einstein School of Medicine, New Hyde Park, NY, USA

    The Department of Anesthesiology, Maimonides Medical Center, Brooklyn, NY, USA.
    Search for articles by this author
  • Hendrick B. Barrier
    Affiliations
    From the Department of Anesthesiology, Syosset Community Hospital, Syosset, NY, USA

    Division of Cardiothoracic Surgery, Long Island Jewish Medical Center, USA

    The Albert Einstein School of Medicine, New Hyde Park, NY, USA

    The Department of Anesthesiology, Maimonides Medical Center, Brooklyn, NY, USA.
    Search for articles by this author
  • Ketan Shevde
    Correspondence
    Address reprint requests to Dr Ketan Shevde, Director, Department of Anesthesiology, Maimonides Medical Center, 4802 10th Ave, Brooklyn, AT 11219.
    Affiliations
    From the Department of Anesthesiology, Syosset Community Hospital, Syosset, NY, USA

    Division of Cardiothoracic Surgery, Long Island Jewish Medical Center, USA

    The Albert Einstein School of Medicine, New Hyde Park, NY, USA

    The Department of Anesthesiology, Maimonides Medical Center, Brooklyn, NY, USA.
    Search for articles by this author
DOI:https://doi.org/10.1016/1053-0770(93)90173-I
Adenosine and myocardial protection
Previous ArticleCerebral hyperperfusion syndrome following aortocarotid bypass surgery
Next ArticleCase 4—1993 Inhaled nitric oxide for right ventricular failure after heart transplantation
      This paper is only available as a PDF. To read, Please Download here.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Berne R.M.
        The role of adenosine in the regulation of coronary blood flow.
        Circ Res. 1980; 47: 807-813
        • Belardinelli L.
        • Linden J.
        • Berne R.M.
        Tje cardiac effects of adenosine.
        Prog Cardiovasc Dis. 1989; 32: 73-97
        • Freilich A.
        • Tepper D.
        Adenosine and its cardiovascular effects.
        Am Heart J. 1992; 123: 1324-1328
        • Ely S.W.
        • Berne R.M.
        Protective effects of adenosine in myocardial ischemia.
        Circulation. 1992; 85: 893-904
        • Leung J.
        • Stanley T.
        • Mathew J.
        • et al.
        Effects of acadesine on perioperative cardiac morbidity in a placebo-controlled, doubleblind study.
        J Am Coll Cardiol. 1992; 19: 112A
        • Platt M.R.
        • Parkey R.W.
        • Willerson J.T.
        • et al.
        Technetium stannous pyrophosphate myocardial scintigrams in the recognition of myocardial infarction in patients undergoing coronary artery revascularization.
        Ann Thorac Surg. 1979; 21: 311-317
        • Val P.G.
        • Pelletier C.
        • Hernandez M.G.
        • et al.
        Diagnostic criteria and prognosis of perioperative myocardial infarction following coronary bypass.
        J Thorac Cardiovasc Surg. 1983; 86: 878-886
        • Burns R.J.
        • Gladstone P.J.
        • Tremblay P.C.
        • et al.
        Myocardial infarction determined by technetium-99m pyrophosphate singlephoton tomography complicating elective coronary artery bypass grafting for angina pectoris.
        Am J Cardiol. 1989; 63: 1429-1434
        • Cheng D.C.H.
        • Chung F.
        • Burns R.J.
        • et al.
        Postoperative myocardial infarction documented by technetium pyrophosphate scan using single-photon emission computed tomography: Significance of intraoperative myocardial ischemia and hemodynamic control.
        Anesthesiology. 1989; 71: 818-826
        • Jones E.L.
        • Weintraub W.S.
        • Craver J.M.
        • et al.
        Coronary bypass surgery: Is the operation different today?.
        J Thorac Cardiovasc Surg. 1991; 101: 108-115
        • Barner H.B.
        • Standeven J.D.
        • Jellinek M.
        • et al.
        Topical cardiac hypothermia for myocardial preservation.
        J Thorac Cardiovasc Surg. 1977; 73: 856-867
        • Laks H.
        • Barner H.B.
        • Hahn J.
        • et al.
        Myocardial protection with intermittent coronary perfusion using cold blood versus a cardioplegic solution.
        Surg Forum. 1977; 28: 231-234
        • Laks H.
        • Barner H.B.
        • Standeven J.W.
        • et al.
        Myocardial protection by intermittent cardioplegic solutions versus intermittent coronary perfusion with cold blood.
        J Thorac Cardiovasc Surg. 1978; 76: 158-172
        • Laks H.
        • Barner H.B.
        • Kaiser G.C.
        A simple method of cold coronary perfusion.
        Ann Thorac Surg. 1978; 25: 351-353
        • Barrier H.B.
        • Kaiser G.C.
        • Codd J.E.
        • et al.
        Clinical experience with cold blood as the vehicle for hypothermic potassium cardioplegia.
        Ann Thorac Surg. 1978; 29: 224-227
        • Laks H.
        • Barner H.B.
        • Kaiser G.C.
        Cold blood cardioplegia.
        J Thorac Cardiovasc Surg. 1979; 77: 319-322
        • Barnet H.B.
        • Laks H.
        • Codd J.E.
        • et al.
        Cold blood as the vehicle for potassium cardioplegia.
        Ann Thoracic Surg. 1979; 28: 509-521
        • Barner H.B.
        • Kaiser G.C.
        • Codd J.F.
        • et al.
        Clinical experience with cold blood as the vehicle for hypothermic potassium cardioplegia.
        Ann Thorac Surg. 1980; 29: 224-227
        • Jellinek M.
        • Standeven J.W.
        • Hahn J.W.
        • et al.
        Cold blood potassium cardioplegia: Effects of increasing concentrations of potassium.
        J Thorac Cardiovasc Surg. 1981; 82: 26-37
        • Sollevi A.
        • Schmidt W.
        • Jansson E.
        • et al.
        Adenine nucleotide degradation in the human myocardium during cardioplegia.
        Cardiovasc Res. 1987; 21: 358-361
        • Weisel R.D.
        • Mickle D.A.G.
        • Finkle C.D.
        • et al.
        Delayed myocardial metabolic recovery after blood cardioplegia.
        Ann Thorac Surg. 1989; 48: 503-507
        • Christakis G.T.
        • Weisel R.D.
        • Mickle D.A.G.
        • et al.
        Right ventricular function and metabolism.
        Circulation. 1990; 82: IV332-IV340
        • Smolenski R.T.
        • Skladanowski A.C.
        • Perko M.
        • Zydowo M.M.
        Adenylate degradation products release from the human myocardium during open heart surgery.
        Clin Chim Acta. 1989; 182: 63-74
        • Ely S.W.
        • Tribble C.G.
        • Linden J.
        • Berne R.M.
        Adenosine concentrations in normal and ischemic regions of the human myocardium.
        J Am Coll Card. 1992; 19: 191A
        • Louagie Y.A.G.
        • Collard E.
        • Gonzalez M.
        • et al.
        Initial experience with low-potassium cold blood cardioplegia: A clinical comparative study.
        Ann Thorac Surg. 1992; 53: 628-634
        • Arom K.V.
        • Emery R.W.
        Coronary sinus card ioplegia: Clinical trial with only retrograde approach.
        Ann Thorac Sure. 1992; 53: 965-971
        • Lessana A.
        • Romano M.
        • Singh Al.
        • et al.
        Beyond cold cardioplegia.
        Ann Thorac Surg. 1992; 53: 666-669
        • Walter P.J.
        • Flameng W.
        • Kindl R.
        • Podzuweit T.
        Preservation of myocardial energy-rich phosphates by retrograde applications of Bretschneider cardioplegia during aortocoronary bypass surgery.
        Eur J Cardiothoracic Surg. 1988; 2: 25-30
        • Usui A.
        • Hotta T.
        • Hisoura M.
        • et al.
        Retrograde cerebral perfusion through a superior vena caval cannula protects the brain.
        Ann Thorac Surg. 1992; 53: 47-53
        • Sinclair L.A.
        • Koch J.P.
        • Deemar K.A.
        • Christakis G.K.
        Warm heart surgery: Is the bypass run different than in cold heart surgery?.
        Can J Anaesthesia. 1992; 39: A24
        • Glick M.R.
        • Gehman J.D.
        • Gascho J.A.
        Adenosine increases total venous capacitance in awake instrumented rats.
        J Cardiovasc Pharm. 1992; 19: 709-713
        • Lawson N.
        Therapeutic combinations of vasopressors and inotropic agents.
        Sem Anesth. 1990; 9: 270-287
        • Kitakaze M.
        • Hori M.
        • Sato H.
        • et al.
        Beneficial effects of a,-adrenergic activity on myocardial stunning in dogs.
        Circ Res. 1991; 68: 1322-1339
        • Smiley R.M.
        • Vulliemoz Y.
        Cardiac surgery causes desensitization of the β-adrenergic receptor system of human lymphocytes.
        Anesth Analg. 1992; 74: 212-218
        • Mueller R.A.
        • Saltzman L.S.
        • Isley M.R.
        • et al.
        Plasma adenosine changes during cardiac surgery.
        J Cardiothorac Vase Anesth. 1991; 5: 444-448
        • Borst M.M.
        • Deussen A.
        • Schrader J.
        S-Adenosylhomocysteine hydrolase activity in human myocardium.
        Cardiovasc Res. 1992; 26: 143-147
        • Illes R.W.
        • Silverman N.A.
        • Krukenkamp I.B.
        • et al.
        The efficacy of blood cardioplegia is not due to oxygen delivery.
        J Thorac Cardiovasc Surg. 1989; 98: 1051-1056
        • Wyatt D.A.
        • Edmunds M.C.
        • Rubio R.
        • et al.
        Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A,adenosine receptors.
        Am J Physiol. 1989; 257: H1952-H1957
        • Boyer P.H.
        • Chance B.
        • Ernester L.
        • et al.
        Oxidative phosphorylation and photophosphorylation.
        Ann Rev Biochem. 1977; 46: 955-1026
        • Jennings R.B.
        • Steenberger Jr, C.
        Nucleotide metabolism and cellular damage in myocardial ischemia.
        Ann Rev Physiol. 1977; 47: 727-749
        • Miller W.L.
        • Belardinelli L.
        • Bacchus A.
        • et al.
        Canine myocardial adenosine and lactate production, oxygen consumption, and coronary blood flow during stellate ganglia stimulation.
        Circ Res. 1979; 45: 708-718
        • Borst M.M.
        • Schrader J.
        Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine.
        Circ Res. 1991; 68: 797-806
        • Lerman B.B.
        • Belardinelli L.
        Cardiac electrophysiology of adenosine: Basic and clinical concepts.
        Circulation. 1991; 83: 1499-1509
        • Taddei S.
        • Pedrinelli R.
        • Salvetti A.
        Sympathetic nervous system-dependent vasoconstriction in humans: Evidence for mechanistic role of endogenous purine compounds.
        Circulation. 1990; 82: 2061-2067
        • Lasley R.
        • Rhee J.
        • VanWylen D.
        • Mentzer R.
        Adenosine A1 receptor mediated protection of the globally ischemic isolated rat heart.
        J Mol Cell Cardiol. 1990; 22: 39-47
        • Cronstein B.N.
        • Rosenstein E.D.
        • Kramer S.B.
        • et al.
        Adenosine: A physiological modulator of superoxide anion generation by human neutrophils. Adenosine acts via A2 receptor on human neutrophils.
        J Immunol. 1985; 135: 1366-1371
        • Cronstein B.N.
        • Levin R.I.
        • Belanoff J.
        • et al.
        Adenosine is an endogenous inhibitor of neutrophil mediated injury to endothelial cells.
        J Clin Invest. 1986; 78: 760-770
        • Roberts P.A.
        • Newby A.C.
        • Hallett M.B.
        • Campell A.K.
        Inhibition by adenosine of reactive oxygen metabolite production by human polymorphonuclear leucocytes.
        Biochem J. 1985; 227: 669-679
        • Cusak N.J.
        • Hourain S.M.O.
        5′-N-ethylcarboxamideoadeno-sine: A potent inhibitor of human platelet aggregation.
        Br J Pharmacol. 1981; 72: 443-447
        • Kitakaze M.
        • Hori M.
        • Sato H.
        • et al.
        Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs.
        Cire Res. 1991; 69: 1402-1408
        • Harder D.R.
        • Belardinelli L.
        • Sperelakis N.
        • et al.
        Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries.
        Circulation. 1979; 44: 176-182
        • Sato H.
        • Masatsugu H.
        • Kitakaze M.
        • et al.
        Endogenous adenosine blunts β-adrenoceptor-mediated inotropic response in hypoperfused canine myocardium.
        Circulation. 1992; 85: 1594-1603
        • Gorman M.W.
        • Ning X.H.
        • He M.X.
        • et al.
        Adenosine release and high-energy phosphates in intact dog hearts during norepinephrine infusion.
        Circ Res. 1992; 70: 1146-1151
        • Louie E.K.
        • Hariman R.J.
        • Wang Y.G.
        • et al.
        Coronary vascular resistance is more responsive to exogenous serotonin than adenosine after a brief period of ischemia followed by reperfusion.
        J Am Coll Card. 1992; 19: 117A
        • Deussen A.
        • Borst M.
        • Kroll K.
        • Schrader J.
        Formation of S-adenosylhomocysteine in the heart. II: A sensitive index for regional myocardial underperfusion.
        Circ Res. 1988; 63: 250-261
        • Deussen A.
        • Walter C.
        • Borst M.
        • Schrader J.
        Transmural gradient of adenosine in canine heart during functional hyperemia.
        Am J Physiol. 1991; 260: H671-H680
        • Lauer M.R.
        • Young C.
        • Liem L.B.
        • et al.
        Mechanism of AV node blockade by adenosine is independent of its inhibition of β-adrenergic activation.
        J Am Coll Cardiol. 1992; 19: 341A
        • Sylvén C.
        • Beermann B.
        • Jonzon B.
        • Brandt R.
        Angina pectoris-like pain provoked by intravenous adenosine in healthy volunteers.
        Br Med J. 1986; 293: 227-230
        • Sylvén C.
        • Beerman B.
        • Edlund A.
        • et al.
        Provocation of chest pain in patients with coronary insufficiency using the vasodilator adenosine.
        Eur Heart J. 1988; 9: N6-N10
        • Crea F.
        • El-Tamimi H.
        • Vejar M.
        • et al.
        Adenosine-induced chest pain in patients with silent and painful myocardial ischaemia: Another clue to the importance of generalized defective perception of painful stimuli as a cause of silent ischaemia.
        Eur Heart J. 1988; 9: N34-N39
        • Crea F.
        • Pupita G.
        • Galassi A.R.
        • et al.
        Role of adenosine in the pathogenesis of anginal pain.
        Circulation. 1990; 81: 164-172
        • Biaggioni I.
        • Killian T.J.
        • Mosquedo-Garcia R.
        • et al.
        Adenosine increases sympathetic nerve traffic in humans.
        Circulation. 1991; 83: 1668-1675
        • Jobe R.L.
        • Gallagher J.J.
        Use of adenosine during hypotension in the Wolff-Parkinson-White syndrome with supraventricular tachycardia.
        Am Heart J. 1991; 121: 1239-1241
        • DiMarco J.P.
        • Sellers T.D.
        • Lerman B.B.
        • et al.
        Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias.
        J Am Coll Cardiol. 1985; 6: 417-425
        • Overhalt E.D.
        • Rheuban K.S.
        • Gutgesell H.P.
        • et al.
        Usefulness of adenosine for arrhythmias in infants and children.
        Am J Cardiol. 1988; 61: 336-340
        • Garratt C.
        • Linker N.
        • Griffith M.
        • et al.
        Comparison of adenosine and verapamil for termination of paroxysmal junctional tachycardia.
        Am J Cardiol. 1989; 64: 1310-1316
        • Belardinelli L.
        • Lerman B.B.
        Electoprophysiologic basis for the use of adenosine in the diagnosis and treatment of cardiac arrhythmias.
        Br Heart J. 1990; 63: 3-4
        • Miles W.M.
        • Zipes D.P.
        Preexcitation syndromes.
        in: Hurst J.W. Current Therapy in Cardiovascular Disease. ed 3. Becker, Philadelphia, PA1991: 77-89
        • Zipes D.P.
        Management of cardiac arrhythmias: Pharmacological, electrical, and surgical techniques.
        in: ed 4. Heart Diseases: A Textbook of Cardiovascular Medicine. Saunders, Philadelphia, PA1992: 628-666
        • Wang G.Y.
        • Wei J.
        • Lin C.I.
        Depressant effect of adenosine in isolated human and canine atrial fibres.
        Cardiovasc Res. 1991; 25: 31-35
        • Song Y.
        • Thedford S.
        • Lerman B.B.
        • Belardinelli L.
        Adenosinesensitive afterdepolarizations and triggered activity in guinea pig ventricular myocytes.
        Cire Res. 1992; 70: 743-753
        • Rossi A.F.
        • Kipel G.
        • Golinko R.J.
        • Griepp R.B.
        Use of adenosine in postoperative junctional ectopic tachycardia with 1:1 retrograde atrial conduction.
        Am Heart. 1991; 121: 1237-1239
        • Stemp L.I.
        • Roy W.L.
        Adenosine for the cardioversion of supraventricular tachycardia during general anesthesia and open heart surgery.
        Anesthesiology. 1992; 76: 849-852
        • Forman M.B.
        • Virmani R.
        • Puett D.W.
        Mechanism and therapy of myocardial reperfusion injury.
        Circulation. 1990; 81: IV69-IV79
        • Reimer K.A.
        • Lowe J.E.
        • Rasmussen M.M.
        • Jennings R.B.
        The wavefront phenomenon of ischemic cell death: I. Myocardial infarct size vs. duration of coronary occlusion in dogs.
        Circulation. 1977; 56: 786-794
        • Hearse D.I.
        • Humphrey S.M.
        • Bullock G.R.
        The oxygen paradox and the calcium paradox: Two facets of the same problem?.
        J Mol Cell Cardiol. 1978; 10: 641-668
        • hearse D.J.
        • Garlick P.B.
        • Humphrey S.M.
        Ischernic contracture of the myocardium mechanism and prevention.
        Am J Cardiol. 1971; 39: 986-993
        • Quaife R.A.
        • Kohmoto O.
        • Barry W.H.
        Mechanisms of reoxvgenation injury in cultured ventricular myocytes.
        Circulation. 1991; 83: 566-577
        • Engler R.L.
        • Schmid-Schoenbein G.W.
        • Pavelcc R.S.
        Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.
        Am J Pathol. 1983; 111: 98-111
        • Dreyer W.J.
        • Michael L.H.
        • West S.
        • et al.
        Neutrophil accumulation in ischemic canine myocardium: Insights into time course, distribution. and mechanism of localization during early reperfusion.
        Circulation. 1991; 84: 400-411
        • Pasque M.K.
        • Wechsler A.S.
        Metabolic intervention to affect myocardial recovery following ischemia.
        Ann Surg. 1984; 200: 1-11
        • Silverman N.A.
        • Kohler J.
        • Feinberg H.
        • Levitskv S.
        Beneficial metabolic effect of nucleoside augmentation on reperfusion injury following cardioplegic arrest.
        Chest. 1983; 83: 787-792
        • Mauser M.
        • Hoffmeister H.M.
        • Nienaber C.
        • Schaper W.
        Influence of ribose- adenosine, and “AICAR” on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog.
        Circ Res. 1985; 56: 220-230
        • Olafsson B.
        • Forman M.B.
        • Puen D.W.
        • et al.
        Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: Importance of the endothelium and the no-reflow phenomenon.
        Circulation. 1987; 76: 1135-1145
        • Homeister J.W.
        • Hoff P.T.
        • Fletcher D.D.
        • Lucchesi B.R.
        Combined adenosine and lidocaine administration limits myocardial reperfusion injury.
        Circulation. 1990; 82: 595-6118
        • Babitt D.G.
        • Virami R.
        • Forman M.B.
        Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.
        Circulation. 1989; 80: 1388-1399
        • Fiore A.C.
        • Naunheim K.S.
        • Tauh J.
        • et al.
        Myocardial preservation using lidocaine blood cardioplegia.
        Ann Thorac Surg. 1990; 50: 771-775
        • Velasco C.E.
        • Turner M.
        • Cobh M.A.
        • et al.
        Myocardial reperfusion injury in the canine model after 411 minutes of ischemia: Effect of intracoronary adenosine.
        Anm Heart J. 1991; 122: 1561-1570
        • Gerlock T.
        • Bentsen D.
        • Weiss H.R.
        Local adenosine infusion and myocardial oxygen supply and consumption in reperfused canine myocardium.
        Cardiovasc Res. 1991; 25: 630-636
        • Honig C.R.
        Modern cardiovascular physiology.
        in: ed 2. Little, Brown, Boston, MA1988: 153-1711
        • Young J.A.
        • Lichtman M.A.
        • Cohen J.
        Reduced red cell 2,3-diphosphoglyceratc and adenosine triphosphate. hypophosphatemia, and increased hemoglobin-oxygen affinity after cardiac surgery.
        Circulation. 1973; 47: 1313-1318
        • Pitayrs C.J.
        • Virami R.
        • Vildibill H.D.
        • Jackson E.K.
        • Forman M.B.
        Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.
        Circulation. 1991; 83: 237-247
        • Babbit D.G.
        • Virami R.
        • Vildibill H.D.
        • Norton E.D.
        • Forman M.B.
        Intracoronarv adenosine administration during reperfusion following 3 hours ischemia: Effects on infarct size, ventricular function, and regional myocardial blood flow.
        Am Heart J. 1990; 120: 808-818
        • Norton E.D.
        • Jackson E.K.
        • Virami R.
        • Forman M.B.
        Effect of intravenous adenosine on myocardial repel fusion injury in a model with low myocardial collateral blood flow.
        Am Heart J. 1991; 122: 128-1291
        • Goto M.
        • Miura T.
        • Iliodoromitis E.K.
        • et al.
        Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species.
        Cardiovasc Research. 1991; 25: 943-949
        • Norton E.D.
        • Jackson E.K.
        • Turner M.B.
        • et al.
        The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury.
        Am Heart J. 1992; 123: 332-338
        • Janier M.
        • Vanoverschelde J.L.
        • Whellan D.
        • et al.
        Attenuation of myocardial ischemic and reperfusion damage by exogenous adenosine is mediated by adenosine receptors.
        J Am Coil Cardiol. 1992; 19: 334A
        • Lust R.M.
        • Li C.
        • Chitwood Jr, R.
        Coronary responses to adenosine are altered in receptor specific (A2) fashion with left ventricular hypertrophy (LVH).
        Circulation. 1991; 84: II-264
        • Torssell L.
        • Ekestrom S.
        • Sollevi A.
        Adenosine-induced increased in-graft flow during coronary bypass surgery.
        Scand J Thorac Cardioyasc Surg. 1989; 23: 235-239
        • Zäll S.
        • Milocco I.
        • Ricksten S-E.
        Effects of adenosine on myocardial blood flow and metaholism after coronary artery bypass surgery.
        Anesth Analg. 1991; 73: 689-695
        • Hershberger R.E.
        • Feldman A.M.
        • Bristow M.R.
        A1-adenosine receptor inhibition of the adenylate cyclase in failing and nontailine human ventricular myocardium.
        Circulation. 1991; 83: 1343-1351
        • Demmy T.L.
        • Magovern J.A.
        • Kao R.L.
        • Magovern G.J.
        Resuscitation of injured myocardium with adenosine and biventricular assist.
        Ann Thorac Surg. 1991; 52: 1044-1051
        • Haywood G.
        • Sneddon Bashir Y.
        • et al.
        Haemodynamic assessment of Al and A2 effects of adenosine in patients with biventricular failure.
        J Am Coll Cardiology. 1993; 19: 331A
        • Roberts A.J.
        • Jacobstein J.G.
        • Cipriano P.R.
        • et al.
        Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction.
        Circulation. 1980; 61: 228-236
        • Teoh K.H.
        • Christakis G.T.
        • Weisel R.D.
        • et al.
        Dipyridamole reduced myocvardial platelet and leukocyte deposition following ischemia and cardioplegia.
        J Surg Res. 1987; 42: 642-652
        • Teoh K.H.
        • Christakis G.T.
        • Weisel R.
        • et al.
        Dipyridamolepreserved platelets and reduced blood loss after cardiopulmonary bypass.
        J Thorac Cardiovasc Surg. 1988; 96: 332-341
        • Kenny D.
        • Wynsen J.C.
        • Brooks H.L.
        • Warltier D.C.
        Dipyridamole-induced decrement of functional recovery of postischemic reperfused myocardium in conscious dogs with well developed coronary collateral circulation.
        Am Heart J. 19911; 121: 1339-1347
        • Banker M.C.
        • Hicks G.L.
        • Tibi P.
        • Pearce F.
        Metabolic and functional cardiac impairment after reperfusion with persantine.
        J Surg Res. 1991; 51: 154-157
        • Murakumi H.
        • Kim S.J.
        • Lee S.C.
        • Strete D.
        • Downey H.F.
        Adenosine exacerbates ischemic myocardial injury during regional coronary hypoxemia in the dog.
        Jpn Heart J. 1990; 31: 365-383
        • Borst M.M.
        • Schrader J.
        Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine.
        Circ Res. 1991; 68: 797-806
        • Gross M.A.
        • Banerjee A.
        • St. Cyr J.A.
        • et al.
        Cardiac 5′- nucleotidase activity increases with age and inversely relates to recovery from ischemia.
        J Thorac Cardiovasc Sure. 1992; 103: 206-209
        • Bolling S.F.
        • Olszanski D.A.
        • Bove E.L.
        • Childs K.F.
        Enhanced myocardial protection during global ischemia with 5′-nucleotidase inhibitors.
        J Thorac Cardiovasc Surg. 1992; 103: 73-77
        • Saleem Y.
        • Niveditha T.
        • Sadasivudu B.
        AMP deaminase, 5′-nucleotidase and adenosine deaminase in rat myocardial tissue in myocardial infarction and hypothernmia.
        Experientia. 1982; 38: 776-777
        • Abd-Elfattah A.S.
        • Jessen M.E.
        • Hanan S.A.
        • Tuchy G.
        • Wechsler A.S.
        Is adenosine 5′-triphosphate derangement or free-radical-mediated injury the major cause of ventricular dysfunction during reperfusion? Role of adenine nucleoside transport in myocardial reperfusion injury.
        Circulation. 1990; 82: IV341-IV345
        • Forman M.B.
        • Virami R.
        • Puett D.W.
        Mechanisms and therapy of myocardial reperfusion injury.
        Circulation. 1990; 81: IV69-IV78
        • Fukunaga A.F.
        • Miyamato T.
        Effects of adenosine after coronary artery bypass surgery.
        Anesth Analg. 1992; 75: 148-150
        • Galiñanes M.
        • Chambers D.J.
        • Hearse D.J.
        Should adenosine continue to be ignored as a card ioprotective agent in cardiac operations?.
        J Thorac Cardiovasc Surg. 1993; 105: 180-183
        • Schubert T.
        • Vetter H.
        • Owen P.
        • et al.
        Adenosine cardioplegia.
        J Thorac Cardiovasc Surg. 1989; 98: 1057-1065
        • de Jong J.W.
        • van der Meer P.
        • van Loon H.
        • et al.
        Adenosine as adjunct to potassium cardioplegia: Effect on function, energy metabolism, and electrophysiology.
        J Thorac Cardiovasc Surg. 1990; 100: 445-454
        • Bolling S.F.
        • Bies L.E.
        • Gallagher K.P.
        • Bove E.L.
        Enhanced myocardial protection with adenosine.
        Ann Thorac Surg. 1989; 47: 809-815
        • Bolling S.F.
        • Bies L.E.
        • Bove E.L.
        • Gallagher K.P.
        Augmenting intracellular adenosine improves myocardial recovery.
        J Thorac Cardiovasc Surg. 1990; 99: 469-474
        • Wyatt D.A.
        • Ely S.W.
        • Lasley R.D.
        • et al.
        Purine-enriched asanguineous cardioplegia retards adenosine triphosphate degradation during ischemia and improves postischemic ventricular function.
        J Thorac Cardiovasc. 1989; 97: 771-778
        • Boehm D.H.
        • Human P.A.
        • Reichenspurner H.
        • et al.
        Adenosine and its role in cardioplegia: Effects on postischemic recovery in the baboon.
        in: Trans Proc. 22. 1990: 545-546
        • Keller M.W.
        • Geddes L.
        • Spotnitz W.
        • et al.
        Microcirculatory dysfunction following perfusion with hyperkalemic, hypothermic, cardioplegic solutions and blood reperfusion: Effects of adenosine.
        Circulation. 1991; 84: 2485-2494
        • Byrne J.G.
        • Applevard R.F.
        • Lee C.C.
        • et al.
        Controlled reperfusion of the regionally ischemic myocardium with leukocytedepleted blood reduces stunning, the no-reflow phenomenon, and infarct size.
        J Thorac Cardiovasc Surg. 1992; 103: 66-72
        • Bical O.
        • Gerhardt M.F.
        • Paumier D.
        • et al.
        Comparison of different types of cardioplegia and reperfusion on myocardial metabolism and free radical activity.
        Circulation. 1991; 84: III375-III379
        • Johnson W.D.
        • Kayser K.L.
        • Brenowitz J.B.
        • Saedi S.F.
        A randomized controlled trial of allopurinol in coronary bypass surgery.
        Am Heart J. 1991; 121: 20-24
        • Lowy B.A.
        • Williams M.K.
        Lesch-Nyhan syndrome: The synthesis of inosine 5′-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
        Pediat Res. 1977; 11: 691-694
        • Thomas C.B.
        • Meade J.C.
        • Holmes E.W.
        Aminoimidazole carboxamide ribonucleoside toxicity: A model for study of pyrimidine starvation.
        J Cell Physiol. 1977; 107: 334-335
        • Sabina R.L.
        • Kernstine K.H.
        • Boyd R.L.
        • et al.
        Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle.
        J Biol Chem. 1982; 257: 10178-10183
        • Engler R.
        Consequences of activation and adenosinemediated inhibition of granulocytes during myocardial ischemia.
        in: Fed Proc. 46. 1987: 2407-2412
        • Gruber H.E.
        • Hoffer M.E.
        • McAllister D.R.
        • et al.
        Increased adenosine concentration in blood from ischemic myocardium by AICA riboside: Effects on flow, granulocytes, and injury.
        Circulation. 1989; 80: 1400-1411
        • Dorion M.
        • Rouleau J.
        • Kingma Jr, J.G.
        Failure of AICA riboside to limit infarct size during acute myocardial infarction in rabbits.
        J Cardiovasc Pharm. 1992; 19: 69-77
        • Young M.A.
        • Mullane K.M.
        Progressive cardiac dysfunction with repeated pacing-induced ischemia: Protection by AICA-riboside.
        Am J Physiol. 1991; 261: H1570-Hl577
        • Bolling S.F.
        • Groh M.A.
        • Mattson A.M.
        • et al.
        Acadesine (AICA-riboside) improves postischemic cardiac recovery.
        Ann Thorac Surg. 1992; 54: 93-98
        • Metzner E.K.
        • Fox M.H.
        • Potter S.
        • et al.
        Acadesine (AICA riboside) attenuates reperfusion injury and oxidant-induced damage of the heart.
        Adv Exp Med Biol. 1991; 309A: 347
        • Galinanes M.
        • Mullane K.M.
        • Bullough D.
        • Hearse D.J.
        Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat.
        Circulation. 1992; 86: 598-608
        • Czarnecki W.
        • Mathison R.
        • Harmsen E.
        • Tyberg J.V.
        Inosine—A natural modulator of contractility and myocardial blood flow in the ischemic heart?.
        Am Heart J. 1992; 124: 1446-1459
        • Reimer K.A.
        • Murry C.E.
        • Jennings R.B.
        Cardiac adaptation to ischemia (ischemic preconditioning).
        Heart Failure. 1991; 7: 9-14
        • Reimer K.A.
        • Murry C.E.
        • Jennings R.B.
        Cardiac adaptation to ischemia (ischemic preconditioning).
        Heart Failure. 1991; 7: 34
        • Murry C.E.
        • Richard V.J.
        • Reimer K.A.
        • Jennings R.B.
        Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during sustained ischemic episode.
        Circ Res. 1990; 66: 913-931
        • Deutsch E.
        • Berger M.
        • Kussmaul W.G.
        • Hirschfeld J.W.
        • Herrmann H.C.
        • Laskey W.K.
        Adaptation to ischemia during percutaneous transluminal coronary angioplasty: Clinical, hemodynamic, and metabolic features.
        Circulation. 1990; 82: 2044-2051
        • Liu G.S.
        • Thornton J.
        • Van Winkle D.M.
        • Stanley A.W.H.
        • Olsson R.A.
        • Downey J.M.
        Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in the rabbit heart.
        Circ. 1991; 84: 350-356
        • Bunch F.T.
        • Thornton J.
        • Cohen M.V.
        • Downey J.M.
        Adenosine is an endogenous protectant against repetitive ischemic episodes in the heart.
        Am Heart J. 1992; 124: 1440-1446
        • Thornton J.D.
        • Liu G.S.
        • Olsson R.A.
        • Downey J.M.
        Intravenous pretreatment with Al-selective adenosine analogues protects the heart against infarction.
        Circulation. 1992; 85: 659-665
        • lasley R.D.
        • Mentzer Jr, R.M.
        Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism.
        Am J Physiol. 1992; 263: H1460-H1465
        • Thornton J.D.
        • Liu G.S.
        • Olsson R.A.
        • Downey J.M.
        Intravenous pretreatment with Al-selective adenosine analogues protects the heart against infarction.
        Circulation. 1992; 85: 659-665
        • Tsuchida A.
        • Miura T.
        • Miki T.
        • et al.
        Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
        Cardiovasc Res. 1992; 26: 456-461
        • Grover G.J.
        • Sleph P.G.
        • Dzwonczyk S.
        Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine Al-receptors.
        Circulation. 1992; 86: 1310-1316
        • Bolli R.
        • Triana J.F.
        • Jeroudi M.O.
        Prolonged impairment of coronary vasodilation after reversible ischemia. Evidence for microvascular “stunning”.
        Circ Res. 1990; 67: 332-343
        • Conzen P.F.
        • Habazettl H.
        • Christ M.
        • et al.
        Coronary microvessel segmental resistance during vasodilation by isoflurane, nitroglycerin and adenosine in dogs.
        Anesthesiology. 1990; 73: A613
        • Habazettl H.
        • Conzen P.F.
        • Christ M.
        • et al.
        Total resistance and vessel segment resistances during adenosine induced hypotension.
        Anesthesiology. 1990; 73: A645
        • Lowenstein E.
        • Reiz S.
        Effects of inhalation anesthetics on systemic hemodynamic and coronary circulation.
        in: Kaplan J.A. Cardiac Anesthesia. ed 2. Saunders, Philadelphia, PA1987: 1-35
        • Kates R.A.
        Antianginal drug therapy.
        in: Kaplan J.A. Cardiac Anesthesia. ed 2. Saunders, Philadelphia, PA1987: 451-517
        • Buffington C.W.
        • Davis K.B.
        • Gillispie S.
        • Pettinger M.
        The prevalence of steal-prone coronary anatomy in patients with coronary artery disease: An analysis of the coronary artery surgery study registry.
        Anesthesiology. 1988; 69: 721-727
        • O'Young J.
        • Mastrocostopoulos G.
        • Hilgenberg A.
        • et al.
        Myocardial circulatory and metabolic effects of isoflurane and sufentanil during coronary artery surgery.
        Anesthesiology. 1987; 66: 653-658
        • Cason B.A.
        • Verrier E.D.
        • London M.J.
        • Mangano D.T.
        • Hickey R.F.
        Effects of isoflurane and halothane on coronary vascular resistance and collateral myocardial blood flow: Their capacity to induce coronary steal.
        Anesthesiology. 1987; 67: 665-675
        • Leung J.M.
        • Levenson L.
        • Hollenberg M.
        • Mangano D.T.
        Does the choice of anesthetic have an effect on myocardial ischemic during anesthetic induction intubation.
        Anesthesiology. 1990; 73: A99
        • Hartman J.C.
        • Kampine J.P.
        • Schmeling W.T.
        • Warltier D.C.
        Alterations in collateral blood flow produced by isoflurane in a chronically instrumented canine model of multivessel coronary artery disease.
        Anesthesiology. 1991; 74: 120-133
        • Hartman J.C.
        • Kampine J.P.
        • Schmeling W.T.
        • Warltier D.C.
        Steal-prone coronary circulation in chronically instrumented dogs:.Isoflurane versus adenosine.
        Anesthesiology. 1991; 74: 744-756
        • Crystal G.J.
        • Kim S.J.
        • Czinn E.A.
        • et al.
        Intracoronary isoflurane causes marked vasodilation in canine hearts.
        Anesthesiology. 1991; 74: 757-765
        • Christensen C.W.
        • Rosen L.B.
        • Gal R.A.
        • Haseeb M.
        • Lassar T.A.
        • Port S.C.
        Coronary vasodilator reserve: Comparison of effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
        Circulation. 1991; 83: 294-303
        • Khambatta H.J.
        • Sonntag H.
        • Larsen R.
        • et al.
        Global and regional myocardial blood flow and metabolism during equipotent halothane and isoflurane anesthesia in patients with coronary artery disease.
        Anesth Analg. 1988; 67: 936-942
        • Becker L.C.
        Effect of nitroglycerin and dipyridamole on regional left ventricular blood flow during coronary artery occlusion.
        J Clin Invest. 1976; 58: 1287-1296
        • Becker L.C.
        Conditions for vasodilator-induced coronary steal in experimental myocardial ischemic.
        Circulation. 1978; 57: 1103-1110
        • Fisch C.
        Electrocardiography and vectorcardiography.
        in: ed 4. Heart Disease: A Textbook of Cardiovascular Medicine. Saunders, Philadelphia, PA1992: 116-160
        • Furukawa T.
        • Kimura S.
        • Furukawa N.
        • et al.
        Potassium rectifier currents differ in myocytes of endocardial and epicardial origin.
        Circ Res. 1992; 70: 91-103
        • Kaplan J.A.
        • Dunbar R.W.
        • Jones E.L.
        Nitroglycerin infusion during coronary artery surgery.
        Anesthesiology. 1976; 45: 14-21
        • Kaplan J.A.
        • Jones E.L.
        Vasodilator therapy during coronary artery surgery: Comparisons of nitroglycerin and nitroprusside.
        J Thorac Cardiovasc Surg. 1979; 77: 301-309
        • Chiariello M.
        • Gold H.K.
        • Leinbach R.C.
        • et al.
        Comparison between the effects of nitroprusside and nitroglycerine on ischemic injury during acute myocardial infarction.
        Circulation. 1976; 54: 766-773
        • Nguyen T.
        • Heo J.
        • Ogilby D.
        • Iskandrian A.S.
        Single photon emission computed tomography with thallium-201 during adenosine-induced coronary hyperemia: Correlation with coronary arteriography, exercise thallium imaging and two-dimensional echocardiography.
        J Am Col Cardiology. 1990; 16: 1375-1383
        • Verani M.S.
        • Mahmarian J.J.
        • Hixson J.B.
        • et al.
        Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.
        Circulation. 1990; 82: 80-87
        • Coyne E.P.
        • Belvedere D.A.
        • Vande Streek P.R.
        • et al.
        Thallium-201 scintigraphy after intravenous infusion of adenosine compared with exercise thallium testing in the diagnosis of coronary artery disease.
        J Am Coll Cardiol. 1991; 17: 1289-1294
        • Wilson R.F.
        • Wyche K.
        • Christensen B.V.
        • Zimmer S.
        • Laxson D.D.
        Effects of adenosine on human coronary circulation.
        Circulation. 1990; 82: 1595-1606
        • Bolognese L.
        • Rossi L.
        • Sarasso G.
        • et al.
        Silent versus symptomatic dipipyridamole-induced ischemic after myocardial infarction: Clinical and prognostic significance.
        J Am Coll Cardiol. 1992; 19: 953-959
        • Fleisher L.A.
        • Nelson A.H.
        • Rosenbaum S.H.
        Failure of negative dipyridamole thallium scans to predict perioperative myocardial ischaemia and infarction.
        Can J Anaesth. 1992; 39: 179-183
        • Mangano D.T.
        • London M.J.
        • Tuban J.F.
        • et al.
        Dipyridamole thallium-201 scintigraphy as a preoperative screening test. A reexamination of its predictive potential. Study of Perioperative Ischemia Research Group.
        Circulation. 1991; 84: 493-502
        • Biagini A.
        • Maffei S.
        • Baroni M.
        • et al.
        Role of dipyridamoleechocardiography test in the evaluation of coronary reserve after coronary artery bypass grafting.
        J Thorac Cardiovasc Surg. 1991; 101: 116-120
        • Jeevanandam V.
        • Barr M.L.
        • Auteri J.S.
        • et al.
        University of Wisconsin solution for human donor heart preservation: Initial clinical experience.
        Ann Thorac Surg. 1991; 52: 1213-1216
        • Mankad P.
        • Lachno R.
        • Yacoub M.
        Preservation of adenine nucleotides following ischemic and reperfusion: Correlation with functional recovery.
        Adv Exp Med Biol. 1991; 52: 279-284
        • Öwall A.
        • Gordon E.
        • Lagerkranser M.
        • et al.
        Clinical experience with adenosine for controlled hypotension during cerebral aneurysm surgery.
        Anesth Analg. 1987; 66: 229-234
        • Öwall A.
        • Lagerkranser M.
        • Sollevi A.
        Effects of adenosineinduced hypotension on myocardial hemodynamics and metabolism during cerebral aneurysm surgery.
        Anesth Analg. 1988; 67: 228-232
        • Ginsburg R.
        • Fukunaga B.
        • Sasaki S.
        • et al.
        Analgesic activity of intravenous adenosine: A comparison of potency with morphine sulphate.
        Anesthesiology. 1990; 73: A362
        • Seitz P.A.
        • ter Reit M.
        • Rush W.
        • Merrell W.J.
        Adenosine decreases the minimum alveolar concentration of halothane in dogs.
        Anesthesiology. 1990; 73: 990-994

      Article info

      Identification

      DOI: https://doi.org/10.1016/1053-0770(93)90173-I

      Copyright

      © 1993 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX